Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Alibaba Health, indicating a reduction of 192.46 million shares on March 16, while also noting a net increase of 282.96 million shares over the last five trading days [1] - Over the past 20 trading days, Alibaba Health has seen a net increase of 47.19 million shares from southbound funds, with 12 days of net buying [1] - As of now, southbound funds hold 1.992 billion shares of Alibaba Health, representing 12.31% of the company's total issued ordinary shares [1] Group 2 - Alibaba Health Information Technology Co., Ltd. is a holding company providing industrial internet solutions for the medical and pharmaceutical industry, serving as Alibaba Group's flagship platform in the health sector [1] - The company primarily engages in the sales of pharmaceutical health products, operates an e-commerce platform for pharmaceuticals, and offers consumer healthcare services, leveraging technologies such as cloud computing and big data for traceability and digital healthcare [1]
阿里健康(00241.HK):3月16日南向资金减持192.46万股